Helen Huihua Mao

Title: Helen Huihua Mao: Innovator in Immunogenic Compositions

Introduction

Helen Huihua Mao is a prominent inventor based in Tianjin, China. She has made significant contributions to the field of immunology, particularly in the development of vaccines and immunogenic compositions. With a total of 2 patents, her work is paving the way for advancements in disease prevention.

Latest Patents

Helen's latest patents include an immunogenic composition for preventing pneumococcal diseases and a method for enhancing the immunogenicity of epitope peptides of HPV antigens. The first patent provides an immunogenic composition that comprises PspA-MRX1, PspA-EF5668, PspA-EF3296, and PlyL460D. This composition is designed to prevent infection and invasion by covering more than 95% of clinical strains. It is notable for its simple preparation method, low production cost, and suitability for large-scale industrial production. The second patent focuses on a method for enhancing the immunogenicity of HPV antigens by assembling a gene of an HPV antigen into a gene of HBc, resulting in a virus-like particle that can be used to prepare an HPV vaccine.

Career Highlights

Helen Huihua Mao is currently employed at CanSino Biologics Inc., where she continues to innovate in the field of vaccine development. Her work is characterized by a commitment to improving public health through effective immunization strategies.

Collaborations

Helen collaborates with notable colleagues, including Mingming Yang and Xuefeng Yu, who contribute to her research and development efforts.

Conclusion

Helen Huihua Mao's contributions to immunology and vaccine development are significant and impactful. Her innovative patents reflect her dedication to advancing healthcare solutions and preventing infectious diseases.